The Peripheral Neuropathy Research Registry (PNRR) is a prospective cohort of peripheral neuropathy (PN) patients focused on idiopathic axonal peripheral neuropathy. Patients with diabetic, human immunodeficiency virus-, and chemotherapy-induced peripheral neuropathies are enrolled as comparison groups. The PNRR is a multi-center collaboration initiated and funded by the Foundation for Peripheral Neuropathy (FPN) with the objective to recruit a well characterized cohort of patients with different phenotypes and symptoms in each diagnostic category, and to advance research through development of biomarkers and identification of previously unknown causes of PN. The overall goal of the initiative is to find disease-altering treatments and better symptom relief for patients. We present the study design, types of data collected, and characteristics of the first 1150 patients enrolled. We also discuss ongoing analyses on this dataset, including untargeted-omics methodologies.
| INTRODUCTION
extensive information on more than 2000 patients. Here we discuss the study design and characteristics of the 1150 patients phenotyped and biobanked to date.
| METHODS
A common protocol was developed and local institutional review board approval was obtained prior to enrolling any patients. Peripheral neuropathy diagnosis was made by an investigator based on a combination of symptoms and signs. 
| RESULTS
Of the 1150 patients included in this data review, patients with idiopathic PN formed the largest group, accounting for 52% (n = 595) of participants. DPN was the identified cause for 31% of the enrolled patients (n = 360), 10% had HIV-PN (n = 115), and 7% had CIPN (n = 77).
| Demographics
The age of the study participants at the time of enrollment ranged from 22 to 93 years, with a median of 63 years. Eighty percent of participants were between 50 and 80 years old, and 5% were under the age of 40, (Figure 1 ). The median ages were comparable in the DPN, idiopathic PN, and CIPN cohorts, but lower in the HIV group, (Table 1) . Participants with neuropathic pain were significantly younger than those without pain in all disease categories. Figure 2 depicts the race distribution of participants in the PNRR; majority of the patients were Caucasian/white (83%), while only 10% were African American/black. About 60% of the participants in the study were male and 40% were female. Same male:female ratio was also seen in the DPN and idiopathic PN groups, but more than 70% of the patients with HIV-PN were male. Only in the CIPN category more females were enrolled than males ( Table 2) .
Body weight at the time of enrollment ranged from 42 to 174 kg, with a median of 87.4 kg for the entire study population. The DPN group had the highest median body mass index (BMI, 30.9), while the median BMI in the idiopathic PN, HIV-PN, and CIPN groups were more than three points lower, (Table 3) . Almost 40% of all PNRR participants were obese with a BMI of ≥30. 7 Those with DPN were more likely to be obese (57%) compared to the other diagnostic groups (36%).
The percentage of patients with recent onset of symptoms (within the past year) was the highest in the CIPN group, with 30% compared to less than 15% in the other three groups. In the DPN and CIPN groups 50% of the patients reported an onset of symptoms 1-5 years ago, compared to 40% and 45% in the HIV-PN, and idiopathic PN groups, respectively. Only 20% of the CIPN patients reported symptoms for more than 6 years. In the DPN group a third of the patients had long standing PN, 42% for idiopathic PN, and in the HIV-PN group those with symptoms of more than 6 years were the largest subgroup (45%).
| Standardized questionnaire
Numbness was the most common symptom, reported by 85% of all enrolled patients, followed by autonomic symptoms (80%); pain (70%), balance issues (66%), and muscular weakness (56%, Figure 3 ). The prevalence of numbness and balance issues were similar between all four groups. In the DPN group, 77% of the patients reported pain, compared to 64-70% in the other three groups, and 67% of the HIV-PN patients reported weakness, while perceived weakness was reported by 52-57% of DPN, CIPN, and idiopathic PN patients. Autonomic symptoms were also more commonly reported by HIV-PN patients with 91% of them reporting one or multiple symptoms, and less common in the other three groups with 70-81%.
| Pain
Painful paresthesias were reported by 70% of the idiopathic PN and CIPN patients, 66% in the HIV-PN, and by 77% in the DPN group (Table 4) . Painful sensations in the feet were reported by 93% of the patients with painful neuropathy, followed by 53% with paresthesias in the legs, 35% in the hands, 15% in the arms, and 19% in the back, torso, neck, or face. Painful sensations in the hands were more frequently reported by CIPN patients (48%) compared to the other groups (<35%), and non-length dependent pain distributions including the torso, back, neck, or face were more frequently reported by DPN and idiopathic PN (>23%) patients, compared to the CIPN and HIV-PN (<15%).
Patients' ratings of their pain intensities in reference to the Numeric Rating Scale (NRS) followed a normal distribution pattern in the DPN, HIV-PN, and idiopathic PN groups (Figure 4) , with a peak at pain levels 7 or 8 and median rankings of 6 or 7. The median pain intensity was the lowest in the CIPN group.
Other evaluated descriptive pain characteristics were hot, sharp, dull, cold, or how itchy the painful sensation felt and if the patients experienced allodynia. Table 5 lists the mean and median ratings for all evaluated pain characteristic. The DPN and HIV-PN participants reported a more intense and sharper pain than the patients in the other two groups, and the HIV-PN patients also submitted the highest NRS-rankings for dullness and itchiness. Allodynia was more intense for patients with CIPN and HIV-PN, while the patients from the idiopathic PN group reported the lowest ratings. The CIPN participants described their pain more often as cold than those in the other groups. In regard to the time quality aspects for pain, constant stimulus-independent pain with occasional flare-ups was the most commonly reported type of pain in all four groups. Stimulus-independent, constant pain was the least frequently reported pain type for the DPN, CIPN, and idiopathic PN groups (<17%), but was reported by 27% of the HIV-PN participants. 
| Numbness
In all groups, 92 to 96% of participants with numbness indicated their feet were affected. 
| Muscle weakness
Fifty-five percent of all enrolled patients indicated that they had weakness. DPN, idiopathic PN, and CIPN patients most often reported frequent tripping, followed by proximal leg weakness and foot drop, and the percentages were very similar in all three groups.
Participants with HIV-PN most often reported proximal leg weakness, followed by tripping and foot drop ( Figure 6 ). About half of the participants who reported weakness in the lower limbs also reported weakness in arm and hand functions. For the CIPN group, problems with fine motor tasks was the most common issue, while a decreased grip strength was the main complaint in the other three groups.
| Balance
Balance issues were reported by approximately two-thirds of all study participants ( Table 6 ). Prevalence of use of assistive devices and falls were largely similar across all groups.
| Autonomic symptoms
One or more symptoms suggesting autonomic involvement were reported by more than 70% of participants. The most commonly reported symptoms were dry eyes or mouth ( Figure 7 ). More than a third also reported abnormal sweating, with night sweats more common than an overall increase for sweating. Abnormal bowel movements were reported by almost half of the HIV-PN patients, and most of them reported diarrhea, while constipation was more often reported in the other three groups. Erectile dysfunction or ejaculation problems were reported by almost half of the male patients. 
| Sleep impairment

| Muscle cramps
Muscle cramps were reported by 72% of the participants. Frequent muscle cramps (daily) were reported by 21% of those with DPN and HIV-PN compared to <15% among those with CIPN or idiopathic PN.
| Medical history
Cardiac disease, hyperlipidemia, and hypothyroidism were the most commonly reported problems in the idiopathic PN, DPN, and CIPN groups, while the HIV-PN patients most frequently reported kidney problems and hepatitis.
| Neurological examination 3.3.1 | Muscle strength
All major muscle groups were evaluated bilaterally for muscular weakness. In the lower extremities, muscular weakness on exam followed a distal predominant pattern, and most frequently affected toe extension and toe plantar flexion. In the upper extremities, the intrinsic hand muscles and abductor pollicis brevis were most often diagnosed as weakened (Figure 8 ). In the DPN group, 36.8% of the patients were diagnosed with muscle weakness of at least one major muscle group, while in the HIV-PN group only 25% of the patients had reduced muscle strength.
| Reflexes
The evaluations for the biceps, triceps, and brachioradialis reflexes showed the same results within each group: the DPN patients had the highest percentages for areflexia, while brisk reflexes were most frequently reported in the HIV-PN group, and the idiopathic PN patients had the highest percentages of fully preserved upper limb reflexes.
The patellar reflex was absent in 20% in the DPN and CIPN patients, 10% in the idiopathic PN group, and only 3% in the HIV-PN category.
Ankle jerk was the most affected deep tendon reflex in all enrollment Figure 10 depicts the percentages of participants unable to perform the different mobility tasks. Tandem walk was the task that most patients Abbreviations: CIPN, chemotherapy-induced peripheral neuropathy; DPN, diabetic peripheral neuropathy; HIV-PN, human immunodeficiency virus induced peripheral neuropathy; IPN, idiopathic peripheral neuropathy.
| Mobility
FIGURE 5
Areas of numbness reported by the patients in each enrollment category, whereby the wrist was considered the border between hands and arms and the ankle the border between feet and legs. "Other" summarizes reported numbness on torso/trunk, back, neck, and head FIGURE 6 Patients indicating that they have muscular weakness were asked which activities were affected. The graphs show the percentages of patients with weakness reporting problems with the listed tasks. Multiple answers were possible had difficulties with, while a positive Romberg was observed in about 25% of all patients. The DPN patients had the most difficulties performing the five mobility tasks, while the CIPN patients had the least problems with Romberg, gait, and walking on their heels or toes; but 40% of the CIPN patients were unable to perform tandem walk.
| Sensory examination
On sensory evaluations, reduced or absent pinprick sensation distally was the most commonly encountered abnormality in all groups (Table 7 ). This was closely followed by reduced or absent vibration sense in the toes. Proprioception at the hallux was preserved in the majority of the patients.
| Nerve conduction studies
Over 80% of the participants had a Nerve Conduction Study (NCS) performed (Table 8 ). In the idiopathic PN and DPN groups the NCS results were abnormal for >65% of the patients, while the percentage of patients with only sensory nerves affected was higher in the HIV-PN group. In all enrollment categories, predominantly axonal nerve damage was the most common, but 20% of the DPN group had both axonal and demyelinating features (mixed), which is higher than the percentages in the other groups. The percentage of patients with a normal NCS on file was the highest in the idiopathic PN group.
| Skin biopsy
In the idiopathic PN group, when done, the skin biopsy was abnormal and interpreted as showing a length-dependent process for 80% of the patients. In the DPN group the percentage was 85%. In both the CIPN and HIV-PN groups less than 10 patients had an abnormal skin biopsy results entered.
| Diagnostic laboratory testing
The most common abnormal testing result was glucose, and for 80% of the DPN patients the most recent glucose screen was considered abnormal. The median HgbA1c for in the DPN group was 6.3 compared to 5.6 in the three other categories. About 30% of the patients enrolled in the CIPN and HIV-PN group had abnormal protein levels, either in form of monoclonal gammopathy or hypogammaglobulinemia, while the percentages in the DPN and idiopathic PN group were below 20%.
The most frequently found paraprotein was IgA, and hypogammaglobulinemia was more common in the elderly and diabetic patients. About 7% of all the patients had a creatinine level above 1.3 mg/dL, and less than 1% had creatinine levels above 1.7 mg/dL. Only two of the enrolled patients had a vitamin B12 level below 180 pg/mL, 2% had a vitamin B12 between 180 and 200 pg/mL, and another 23% had a vitamin B12 between 200 and 400 pg/mL.
| DISCUSSION AND SUMMARY
This report describes an ongoing natural history cohort of patients with acquired, distal, symmetric axonal peripheral neuropathies at six academic tertiary care centers. In this initial report, we describe the nature of the cohort and collected information. The primary focus of this cohort is patients with idiopathic PN, DPN, CIPN, and HIV-PN. The collected blood samples will be used for a planned genomic study to identify any genetic causes or risk factors for idiopathic PN. Furthermore, the serum and plasma samples will be used for biomarker studies.
A major goal of this prospective cohort study is to be a resource for future research with specific hypotheses. Collaboration through
this consortium is open to both academic and industry researchers. painless small fiber neuropathy. 11 The cause of discrepancy between the previous studies and the patients from the PNRR cohort is unclear and may reflect differences in patient populations or referral patterns.
The PNRR was designed to enroll neuropathy patients seen in a general neurology practice in tertiary referral centers and the patient population may differ from the ones described previously where a high proportion of patients initially considered for the study had sarcoidosis, a rare cause of neuropathy. 9 However, PNRR also has limitations in that patients are enrolled through academic tertiary care centers and may not reflect the disease characteristics of patients in a community setting. Nevertheless, this initial study utilizing the patient samples from the PNRR highlights the utility of the PNRR as a clinical research tool for future studies.
FIGURE 9
Percentages of patients with normal, brisk, reduced, or absent ankle tendon reflex as determined by the examining physician during the neurological examination FIGURE 10 Percentages of patients who are unable to perform specific mobility evaluations during the neurological examination. *Heel and toe walk evaluations were not provided for many human immunodeficiency virus (HIV) patients and the reported percentages represent extrapolations from the available data In addition to the future genomic and biomarker studies, patients enrolled in the PNRR have been consented to be contacted for future clinical studies and will serve as a source of well characterized participants for therapeutic clinical trials. Finally, as patients enrolled in the PNRR are seen for their follow up evaluations, longitudinal data will be collected, which may help evaluate the efficacy of therapeutic interventions. Our goal is to utilize the PNRR as a useful tool and model to stimulate PN research.
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